Literature DB >> 30978132

Direct CD137 costimulation of CD8 T cells promotes retention and innate-like function within nascent atherogenic foci.

Maria M Xu1, Antoine Ménoret1,2, Sarah-Anne E Nicholas3, Sebastian Günther4, Eric J Sundberg4,5,6, Beiyan Zhou1, Annabelle Rodriguez3, Patrick A Murphy3, Anthony T Vella1.   

Abstract

Effector CD8 T cells infiltrate atherosclerotic lesions and are correlated with cardiovascular events, but the mechanisms regulating their recruitment and retention are not well understood. CD137 (4-1BB) is a costimulatory receptor induced on immune cells and expressed at sites of human atherosclerotic plaque. Genetic variants associated with decreased CD137 expression correlate with carotid-intimal thickness and its deficiency in animal models attenuates atherosclerosis. These effects have been attributed in part to endothelial responses to low and disturbed flow (LDF), but CD137 also generates robust effector CD8 T cells as a costimulatory signal. Thus, we asked whether CD8 T cell-specific CD137 stimulation contributes to their infiltration, retention, and IFNγ production in early atherogenesis. We tested this through adoptive transfer of CD8 T cells into recipient C57BL/6J mice that were then antigen primed and CD137 costimulated. We analyzed atherogenic LDF vessels in normolipidemic and PCSK9-mediated hyperlipidemic models and utilized a digestion protocol that allowed for lesional T-cell characterization via flow cytometry and in vitro stimulation. We found that CD137 activation, specifically of effector CD8 T cells, triggers their intimal infiltration into LDF vessels and promotes a persistent innate-like proinflammatory program. Residence of CD137+ effector CD8 T cells further promoted infiltration of endogenous CD8 T cells with IFNγ-producing potential, whereas CD137-deficient CD8 T cells exhibited impaired vessel infiltration, minimal IFNγ production, and reduced infiltration of endogenous CD8 T cells. Our studies thus provide novel insight into how CD137 costimulation of effector T cells, independent of plaque-antigen recognition, instigates their retention and promotes innate-like responses from immune infiltrates within atherogenic foci. NEW & NOTEWORTHY Our studies identify CD137 costimulation as a stimulus for effector CD8 T-cell infiltration and persistence within atherogenic foci, regardless of atherosclerotic-antigen recognition. These costimulated effector cells, which are generated in pathological states such as viral infection and autoimmunity, have innate-like proinflammatory programs in circulation and within the atherosclerotic microenvironment, providing mechanistic context for clinical correlations of cardiovascular morbidity with increased CD8 T-cell infiltration and markers of activation in the absence of established antigen specificity.

Entities:  

Keywords:  CD137; CD8 T cell; atherosclerosis; inflammation; interferon-γ

Mesh:

Substances:

Year:  2019        PMID: 30978132      PMCID: PMC6620679          DOI: 10.1152/ajpheart.00088.2019

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   5.125


  74 in total

1.  Expression of soluble CD137 correlates with activation-induced cell death of lymphocytes.

Authors:  J Michel; H Schwarz
Journal:  Cytokine       Date:  2000-06       Impact factor: 3.861

2.  Signaling through NK cell-associated CD137 promotes both helper function for CD8+ cytolytic T cells and responsiveness to IL-2 but not cytolytic activity.

Authors:  Ryan A Wilcox; Koji Tamada; Scott E Strome; Lieping Chen
Journal:  J Immunol       Date:  2002-10-15       Impact factor: 5.422

3.  Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus.

Authors:  J M Esdaile; M Abrahamowicz; T Grodzicky; Y Li; C Panaritis; R du Berger; R Côte; S A Grover; P R Fortin; A E Clarke; J L Senécal
Journal:  Arthritis Rheum       Date:  2001-10

4.  Identification of CD137 as a potent monocyte survival factor.

Authors:  J Langstein; H Schwarz
Journal:  J Leukoc Biol       Date:  1999-06       Impact factor: 4.962

5.  Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines.

Authors:  J Frostegård; A K Ulfgren; P Nyberg; U Hedin; J Swedenborg; U Andersson; G K Hansson
Journal:  Atherosclerosis       Date:  1999-07       Impact factor: 5.162

6.  Heightened intrathecal release of soluble CD137 in patients with multiple sclerosis.

Authors:  M K Sharief
Journal:  Eur J Neurol       Date:  2002-01       Impact factor: 6.089

7.  4-1BB ligand-mediated costimulation of human T cells induces CD4 and CD8 T cell expansion, cytokine production, and the development of cytolytic effector function.

Authors:  Tao Wen; Jacob Bukczynski; Tania H Watts
Journal:  J Immunol       Date:  2002-05-15       Impact factor: 5.422

8.  Cutting edge: Expression of functional CD137 receptor by dendritic cells.

Authors:  Ryan A Wilcox; Andrei I Chapoval; Kevin S Gorski; Mizuto Otsuji; Tahiro Shin; Dallas B Flies; Koji Tamada; Robert S Mittler; Haruo Tsuchiya; Drew M Pardoll; Lieping Chen
Journal:  J Immunol       Date:  2002-05-01       Impact factor: 5.422

9.  Trends in survival and cause of death in Danish patients with multiple sclerosis.

Authors:  Henrik Brønnum-Hansen; Nils Koch-Henriksen; Egon Stenager
Journal:  Brain       Date:  2004-02-11       Impact factor: 13.501

10.  Memory CD8+ T cells provide innate immune protection against Listeria monocytogenes in the absence of cognate antigen.

Authors:  Rance E Berg; Emily Crossley; Sean Murray; James Forman
Journal:  J Exp Med       Date:  2003-11-17       Impact factor: 14.307

View more
  5 in total

1.  Optimal CD8+ T cell effector function requires costimulation-induced RNA-binding proteins that reprogram the transcript isoform landscape.

Authors:  Timofey A Karginov; Antoine Ménoret; Anthony T Vella
Journal:  Nat Commun       Date:  2022-06-20       Impact factor: 17.694

Review 2.  Adaptive immunity-driven inflammation and cardiovascular disease.

Authors:  Daria V Ilatovskaya; Ganesh V Halade; Kristine Y DeLeon-Pennell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-11-08       Impact factor: 4.733

Review 3.  Activated T-effector seeds: cultivating atherosclerotic plaque through alternative activation.

Authors:  Maria M Xu; Patrick A Murphy; Anthony T Vella
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-03-29       Impact factor: 5.125

Review 4.  CD8+ T Cells in Atherosclerosis.

Authors:  Sarah Schäfer; Alma Zernecke
Journal:  Cells       Date:  2020-12-29       Impact factor: 6.600

Review 5.  The Progress of Investigating the CD137-CD137L Axis as a Potential Target for Systemic Lupus Erythematosus.

Authors:  Anselm Mak; Herbert Schwarz
Journal:  Cells       Date:  2019-09-06       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.